The Emergency Training Rule Costs Hospitals $173 Million a Year. CMS Just Proposed Killing It.
CMS proposed repealing hospital training mandates in effect since July 2025 and stopping OB rules due Jan. 1, 2027, saving $320 million a year. The catch, and one stock idea.
Key Highlights
- The proposal: CMS would repeal hospital staff training mandates for patient transfers and emergency services readiness, both in effect since July 1, 2025, and stop obstetric training and obstetric quality rules that were due to take effect January 1, 2027.1
- The cost of the paperwork: the emergency readiness training rule alone was estimated to cost hospitals about $173 million and 1.6 million staff hours a year when it was finalized.2
- The package: CMS puts the whole rule at roughly $320 million a year in savings across 21 provider types, returning 3.26 million hours of staff time.3 Hospitals account for $123.2 million a year, long-term care facilities $142.6 million, critical access hospitals $16.6 million.4
- The catch: CMS attaches a new mandate of its own, informed consent and written policies for birth tissue collection, which it estimates will cost hospitals and patients roughly $69 million a year, and CMS itself says the rule cannot be finalized before the January 1 obstetric requirements take effect.5, 6
- The clock: comments are due January 11, 2027.5
On November 5, the Centers for Medicare and Medicaid Services issued a proposed rule with a name that reads like a memo from a frustrated hospital administrator: Cutting Administrative Requirements for Excellence in Patient Care, or the CARE rule. It landed in the Federal Register on November 10, 134 pages long, and it does something federal agencies almost never do voluntarily. It walks back requirements the agency itself imposed on hospitals a year and a half ago.7
The core of it is staff training. Since July 1, 2025, every Medicare-certified hospital has had to run annual training on emergency services readiness, document which staff took it, show they knew the material, and feed the results into its quality program. The same drill applied to patient transfer protocols. A third set of mandates, training on maternal care and obstetric-specific quality improvement, was finalized but does not bite until January 1, 2027. CMS now proposes to repeal all of it.5
When the emergency readiness requirement was finalized, the agency priced it at about $173 million and 1.6 million staff hours a year for hospitals alone.2 That is the number to keep in mind. This is not a story about a form getting shorter. It is a story about a federal agency concluding that a mandate it designed, costed, and defended in court filings is not worth its own invoice.
What Hospitals Actually Had to Do
The training requirements were not one-line obligations. Read the regulation text at 42 CFR 482.55(c)(3), now proposed for removal. The hospital had to identify which staff needed the training, deliver it annually, document completion in personnel files, demonstrate that staff actually knew the material, and use its quality assessment findings to shape future training. Every step generated evidence for a surveyor.7
Now read what stays. Written transfer policies are still required. EMTALA still governs emergency transfers. The discharge planning conditions of participation still apply. Accreditation standards, which most large hospitals answer to anyway, still cover staff competency. CMS's own argument is that this stack of overlapping requirements already forces hospitals to prove the same competence several times over, and that a dedicated annual training mandate adds documentation without adding safety.6
That is the mechanism worth watching, because it generalizes. The rule also deletes the requirement that hospital patient care areas have access to natural light through exterior windows, ends weekly respiratory illness reporting at long-term care facilities outside public health emergencies, and rescinds three Medicaid payment transparency reports that nursing homes file every year.8 The nursing home trade group did not wait for a final rule to celebrate. "Ending weekly reporting requirements that were tied to the public health emergency that ended more than three years ago is recognizing how far we've come since the pandemic," AHCA President Clif Porter said in a statement.9
The Numbers
CMS's summary estimate puts the package at roughly $320 million a year in reduced expenditures across providers, suppliers, states and the federal government, and 3.26 million hours of staff time returned.3 The agency's own math inside the rule is more granular. Hospitals save $123.2 million a year, long-term care facilities $142.6 million, critical access hospitals $16.6 million, and intermediate care facilities $6.6 million. Over ten years the agency counts nearly 29.4 million clinician hours returned and about $2.89 billion in savings.5
Two of the training repeals carry the weight. The transfer protocol training was estimated to cost $81.6 million and 445,535 hours a year. The obstetric staff training that was due January 1 was priced at $58.3 million and more than 5.1 million hours a year once you count every hospital that delivers babies. The obstetric-specific quality improvement rules add another $18.8 million a year for hospitals.5
For scale, there are about 4,700 Medicare-certified hospitals, roughly 15,000 long-term care facilities and about 1,400 critical access hospitals operating under these conditions of participation.5 The hours get handed back in fragments, a few thousand per facility, which is exactly why mandates like this survive. If you run a hospital, you never see the $173 million. You see another Tuesday of training logs.

The Catch
Two of them, and CMS is honest about both in the rule text.
First, the agency is not only subtracting. For hospitals that deliver babies, CMS proposes brand new conditions around birth tissue: informed consent before collection, written policies for families who want to retain placental tissue for cultural or religious reasons, and safe handling instructions. The agency estimates the consent process alone at $69.1 million a year and 394,155 hours, plus $19.2 million in one-time policy costs and $8.3 million a year in ongoing training.5 Set against the training repeal, the net for maternity hospitals is real but thinner than the headline. CMS is trading federal checklists for other federal checklists, and the honest read is that the rule reallocates burden toward a specific patient-rights priority rather than simply deleting it.
Second, the timing. CMS says plainly that the rule cannot be finalized before January 1, 2027, which means the obstetric training and quality mandates take effect first, and hospitals will spend some period complying with requirements the agency is actively trying to repeal.6 An agency that repeals its own mandate after its effective date is not deregulating. It is churning. The compliance departments know the difference, because they are the ones writing and then unwriting the procedures.

The Free-Market Read
Let me steelman the mandates before I argue against them. Maternal mortality in the United States is worse than in peer countries, and it is worse in the hospitals least equipped to handle obstetric emergencies. The 2025 rule was not invented by a bureaucrat with a quota. It came from a real and bipartisan pressure to force rural and small hospitals to rehearse the emergencies they see rarely and handle badly when they do. If you care about outcomes rather than process, a training mandate is a defensible tool.
But process is precisely the problem. A training mandate does not buy competence. It buys documentation of competence, and the two diverge quickly. CMS's own justification for the repeal concedes the point: the agency lists EMTALA, the discharge planning conditions, accreditation standards and general quality improvement requirements as already sufficient to guarantee the same competency, which is an admission that the training rule was asking hospitals to prove something they were already proving elsewhere.10 When a regulator says the redundancy is the safety, the regulator has run out of arguments.
The free-market alternative is not zero rules. It is outcome ownership. Hospitals already answer to malpractice liability, accreditation, EMTALA enforcement and state licensure, all of which punish the actual failure rather than the missing paperwork. A hospital that delivers babies badly gets sued, loses its accreditation or exits the business. A hospital with perfect training files and bad outcomes faces the same consequences. The mandate only changes who can prove diligence in an audit, and audits are not where maternal mortality is decided.
This is also the second CMS package in a week aimed at conditions of participation. Last Friday this report covered the agency's proposal to stop forcing nursing home buyers to tear out old rooms because of a paperwork trigger (Free Markets Report, Nov. 7, 2026). Add the HHS health IT retreat covered in October (Free Markets Report, Oct. 27, 2026) and a pattern is visible: the agency that certifies one fifth of the economy is running a line-by-line teardown of its own rulebook. Each cut is small. The direction is not.
The Bear Case
The rule is a proposal, not a law. Comments run through January 11, 2027, and the maternal health lobby has a genuine constituency and recent bipartisan wins behind it. The obstetric pieces in particular were finalized in the 2025 outpatient payment rule after public comment, so repealing them mid-cycle invites the same procedural challenge any reversal does. It is also fair to note that CMS's savings estimates are the agency grading its own homework. The $320 million figure assumes compliance costs vanish rather than migrate into the birth tissue consent process, which CMS itself prices at $69 million a year.7
The honest counter is that even if the obstetric pieces survive comment, the transfer and emergency readiness repeals are already-effective mandates being rolled back by the same agency that imposed them, with the hospital industry's full support. The American Hospital Association and the Federation of American Hospitals have wanted these training conditions gone since they were finalized. The comment file will not read like a fight.

The Idea
The savings here will not move any hospital's earnings, and you should not buy this idea for the $320 million. HCA Healthcare is the cleanest way to own the trend anyway. At $509.78 in early trading on November 16, HCA trades at 16.9 times trailing earnings on EPS of $28.96, with a market capitalization of $106.5 billion and a 52-week range of $353.99 to $556.52.11 The stock is up 2.15 percent on the day as I write, a few percent below its high.
The thesis is not the $320 million, which across 4,700 hospitals is noise. It is labor and direction. Labor is the largest cost line in hospital operations, and every federal mandate that consumes nursing hours is a tax paid in the scarcest input the sector has. A regulator that returns 3.26 million hours a year, kills its own training rule and telegraphs more of the same is lowering the marginal cost of running a hospital, and scale operators capture regulatory relief better than anyone because they amortize compliance systems across hundreds of facilities. HCA is the largest single owner of that compliance overhead in the country.
What the market may be missing is that this rule is not an isolated favor. It is the third CMS conditions-of-participation package in six weeks, and the agency's own fact sheet brags about a "comprehensive review" of all 21 provider types3, which is regulator language for a pipeline. The market prices announced savings. It rarely prices a process that keeps producing them.
Risks: the rule is proposed, not final, and the obstetric pieces have genuine opposition. HCA at 17 times earnings is not cheap if hospital utilization softens or if payers push back on pricing. And regulatory relief for hospitals can be reversed by the next administration, which is exactly what this rule is doing to the last one's.
What would prove me wrong: CMS finalizes the rule but keeps the emergency readiness training mandate after comment pressure, or the obstetric quality requirements survive in substantially stronger form than proposed. Either one would tell me the conditions-of-participation teardown has hit its political floor, and I would treat the whole regulatory-relief thesis for hospitals as capped rather than compounding. I keep score on every idea here, winners and losers.
What To Watch Next
January 1, 2027 is the first date. The obstetric training and quality mandates take effect that day unless CMS can finish a final rule in under seven weeks, which the agency's own timeline says it cannot. January 11, 2027 is the comment deadline, and the file will show whether the maternal health organizations fight the obstetric repeal or trade it for the birth tissue provisions. Watch whether the final rule, when it comes, keeps the emergency readiness repeal intact, because that is the piece with the largest hospital cost attached. I have added the comment deadline to the Deregulation Investor's Catalyst Calendar.
Know someone who should be reading this?
One deregulation story and one stock idea, every day, free. Send it to someone who thinks markets work better than mandates.
The Free Markets Report is provided by Lead-Lag Publishing, LLC. All opinions and views mentioned in this report constitute our judgments as of the date of writing and are subject to change at any time. Information within this material is not intended to be used as a primary basis for investment decisions and should also not be construed as advice meeting the particular investment needs of any individual investor. Trading signals produced by the Free Markets Report are independent of other services provided by Lead-Lag Publishing, LLC or its affiliates, and positioning of accounts under their management may differ. Please remember that investing involves risk, including loss of principal, and past performance may not be indicative of future results. Lead-Lag Publishing, LLC, its members, officers, directors and employees expressly disclaim all liability in respect to actions taken based on any or all of the information on this writing. Nothing in this report shall be construed as an offer to provide investment advice or services. Nothing in this report shall be construed to be an offer to provide investment advisory services. Nothing in this report shall be construed as an offer or solicitation to buy or sell any security. The Free Markets Report is for informational purposes only and does not constitute a complete description of our investment services or performance. THE INFORMATION IN THIS REPORT HAS BEEN PREPARED WITHOUT REGARD TO THE INDIVIDUAL CIRCUMSTANCES OF INDIVIDUALS WHO MIGHT RECEIVE IT. THE INVESTMENTS DISCUSSED MAY NOT BE SUITABLE FOR ALL INVESTORS. INVESTORS MUST MAKE THEIR OWN INVESTMENT DECISIONS BASED ON THEIR OWN PARTICULAR FINANCIAL SITUATIONS AND OBJECTIVES. This report is not an offer to provide investment advice or services. Nothing in this report shall be construed as an offer to provide investment advice or services. Nothing in this report shall be construed to be an offer to provide investment advisory services in any jurisdiction in which Lead-Lag Publishing, LLC is not authorized to provide such services. All investments involve risk, including the risk of loss of principal. No representation is being made that any security, account, or strategy is or is likely to achieve results similar to those shown. Investing in securities involves risks, and there is always the potential of losing money when you invest in securities. Before investing, consider your investment objectives, and Lead-Lag Publishing, LLC's charges and expenses. This report is not a prospectus and does not contain all of the information necessary to fully evaluate any security or strategy discussed, including, but not limited to, the risk of adverse effects of related market developments. You should not rely solely on the information contained in this report, and should seek advice based on your situation from a licensed investment professional. Carefully consider the investment objectives, risks, charges, and expenses of any investment product before investing. This report may not be copied or distributed without the express written consent of Lead-Lag Publishing, LLC. Any decisions made based on any or all of the information in this writing are the sole responsibility of the user, and the user should exercise caution and take appropriate advice before acting.
Sources
- CMS fact sheet, Nov. 5, 2026 (cms.gov)
- Becker's Hospital Review, Nov. 16, 2026 (beckershospitalreview.com)
- CMS fact sheet (cms.gov)
- Federal Register, 91 FR 72634, Nov. 10, 2026 (federalregister.gov)
- Federal Register, 91 FR 72634 (federalregister.gov)
- HFMA, Nov. 6, 2026 (hfma.org)
- Federal Register, 91 FR 72634 (federalregister.gov)
- Epstein Becker Green, Nov. 12, 2026 (ebglaw.com)
- Becker's Hospital Review (beckershospitalreview.com)
- HFMA (hfma.org)
- Perplexity Finance, HCA quote, Nov. 16, 2026 (perplexity.ai)